According to a significant study, having type 2 diabetes more than doubles the risk of dying from some malignancies. According to British experts, people with diabetes have a twofold increased risk of dying from bowel, liver, pancreatic, and endometrial cancer.
It was shown that younger women with type 2 diabetes, which is frequently associated to obesity, had a higher probability of dying if they had breast cancer. According to the research, cancer may now be the main cause of mortality in type 2 diabetics, surpassing heart attacks and stroke.
Additionally, young women with the disease are more likely to develop breast cancer. According to research, cancer may be one of the main causes of death for those with diabetes.
Words from Health Experts
Some malignancies may be caused by extended exposure to the negative consequences of elevated blood sugar and insulin levels, insulin resistance, and chronic inflammation, according to experts, while others may become more lethal.
They advised officials to take into account extra cancer screening programmes to target people most at risk and cautioned that mortality could rise unless more is done to combat the obesity pandemic. The study accessed data on more than 135,000 Britons aged 35 and older who received a type 2 diabetes diagnosis between 1998 and 2018 using the UK general practise database.
While overall cancer death rates decreased in people under 75, type 2 diabetes-related death rates defied the trend and increased during the past 20 years. The death rates from bowel, liver, and lung cancer all climbed while those from pancreatic, liver, and lung cancer increased across the board. In the meantime, breast cancer rates rose among younger women (those under the age of 55), while rates of prostate and endometrial cancer soared among people 75 and older.
According to Dr. Suping Ling, who oversaw the study conducted by the London School of Hygiene & Tropical Medicine and Leicester Diabetes Research Centre, type 2 diabetes has an impact on cancer mortality rates.
She advised that alterations to current screening programmes or more thorough examinations for suspected or generalised cancer signs in type 2 diabetics may lessen the number of cancer deaths that could have been prevented.
In the UK, more than 4 million individuals have type 2 diabetes, and 13.5 million more are at risk of getting the disease as a result of rising obesity rates.
Up until recently, there had been no research into whether type 2 diabetes affected overall cancer survival, despite mounting evidence that it can cause pancreatic, liver, and endometrial cancers.
Read More News: Click Here